Your browser doesn't support javascript.
loading
Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren's syndrome.
Yucel, H; Vollmer, O; Canuet, M; Enache, I; Kessler, R; Korganow, A S; Riou, M.
Afiliación
  • Yucel H; Service de Pneumologie, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Vollmer O; Centre National de Référence des Maladies Auto-Immunes et Systémiques Rares, Est/Sud-Ouest (RESO), France.
  • Canuet M; Service d'Immunologie clinique, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Enache I; Service de Pneumologie, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Kessler R; Service de Physiologie, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Korganow AS; Service de Pneumologie, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Riou M; Centre National de Référence des Maladies Auto-Immunes et Systémiques Rares, Est/Sud-Ouest (RESO), France.
Lupus ; 30(3): 510-513, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33655792
ABSTRACT

BACKGROUND:

Pulmonary arterial hypertension (PAH), is a rare manifestation of systemic lupus erythematosus (SLE), characterized by pulmonary arterial remodeling leading to right ventricular failure and death. To date, optimal management of SLE-associated PAH should be clarified, especially regarding the respective places of immunosuppressants and PAH vasodilator treatments. CASE REPORT We report the case of a 48-year-old woman with SLE and secondary Sjogren syndrome, associated with severe PAH and lupus peritonitis with massive ascites, who showed a remarkable response, both for SLE flare and PAH, to a treatment combining immunosuppressants and pulmonary arterial vasodilator treatment.

CONCLUSION:

This observation highlights the interest of combining immunosuppressive therapy in SLE-PAH, whose modalities in association with PAH treatments should be clarified.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vasodilatadores / Hipertensión Arterial Pulmonar / Inmunosupresores / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Lupus Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vasodilatadores / Hipertensión Arterial Pulmonar / Inmunosupresores / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Lupus Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Francia
...